ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

2020 - 21 CFR Part 11, FDA's Guidance for Electronic Records and Electronic Signatures

Date2020-11-03

Deadline2020-10-24

VenueOnline event, USA - United States USA - United States

KeywordsGxp systems; Gmp; Glp

Websitehttps://www.complianceonline.com/21-cfr-...esearchbib

Topics/Call fo Papers

Computer System Validation (CSV)
System Development Life Cycle (SDLC) Methodology
Good “Variable” Practice (GxP) (Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), Good Clinical Practice (GCP))
Data Integrity (DI)
Validation Strategy, Planning and Execution
System Risk Assessment
GAMP 5 “V” Model and Software Categorization
21 CFR Part 11, FDA’s Guidance on Electronic Records/Electronic Signatures (ER/ES)
Security, Access, Change Control and Audit Trail
Criteria required to ensure data is created and maintained with integrity through its life cycle
Policies and Procedures to support CSV and DI assurance
Training and Organizational Change Management
Current FDA Trends in Compliance and Enforcement
Industry Best Practices and Common Pitfalls
Q&A

Last modified: 2020-10-05 16:18:18